108 related articles for article (PubMed ID: 14975514)
1. Schizophrenia and cancer: the adrenochrome balanced morphism.
Foster HD; Hoffer A
Med Hypotheses; 2004; 62(3):415-9. PubMed ID: 14975514
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis.
Catts VS; Catts SV; O'Toole BI; Frost AD
Acta Psychiatr Scand; 2008 May; 117(5):323-36. PubMed ID: 18331573
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
[TBL] [Abstract][Full Text] [Related]
4. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
[TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
6. Reduced cancer incidence among patients with schizophrenia.
Barak Y; Achiron A; Mandel M; Mirecki I; Aizenberg D
Cancer; 2005 Dec; 104(12):2817-21. PubMed ID: 16288491
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. On the relationship of adrenaline and its oxidation products to schizophrenia.
FELDSTEIN A
Am J Psychiatry; 1959 Nov; 116():454-6. PubMed ID: 13822066
[No Abstract] [Full Text] [Related]
9. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
Williams NM; Preece A; Morris DW; Spurlock G; Bray NJ; Stephens M; Norton N; Williams H; Clement M; Dwyer S; Curran C; Wilkinson J; Moskvina V; Waddington JL; Gill M; Corvin AP; Zammit S; Kirov G; Owen MJ; O'Donovan MC
Arch Gen Psychiatry; 2004 Apr; 61(4):336-44. PubMed ID: 15066891
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia: who is at risk? Who is a case?
Verdoux H; Cougnard A
Int Clin Psychopharmacol; 2006 Mar; 21 Suppl 2():S17-9. PubMed ID: 16601509
[TBL] [Abstract][Full Text] [Related]
11. The role of aminochromes in ultraweak luminescence accompanying oxidative metabolism of catecholamines in model systems in vitro.
Slawinska D; Slawinski J
Physiol Chem Phys Med NMR; 1991; 23(4):247-60. PubMed ID: 1812504
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity of schizophrenia and cancer: clinical recommendations for treatment.
Damjanović A; Ivković M; Jasović-Gasić M; Paunović V
Psychiatr Danub; 2006 Jun; 18(1-2):55-60. PubMed ID: 16804500
[TBL] [Abstract][Full Text] [Related]
14. The risk for cancer among patients with schizoaffective disorders.
Levav I; Kohn R; Barchana M; Lipshitz I; Pugachova I; Weizman A; Grinshpoon A
J Affect Disord; 2009 Apr; 114(1-3):316-20. PubMed ID: 18675461
[TBL] [Abstract][Full Text] [Related]
15. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
16. [Current status of biochemistry of schizophrenia--endocrine disease].
de Paiva LM
Resen Clin Cient; 1967; 36(9):197-202 concl. PubMed ID: 5633391
[No Abstract] [Full Text] [Related]
17. Biochemical correlates of schizophrenia.
Malek-Ahmadi P; Fried FE
Compr Psychiatry; 1976; 17(4):499-509. PubMed ID: 61095
[No Abstract] [Full Text] [Related]
18. A critical review of endogenous psychotoxins as a cause of schizophrenia.
Throme ML; Gowdey CW
Can Psychiatr Assoc J; 1967 Apr; 12(2):159-74. PubMed ID: 5342389
[No Abstract] [Full Text] [Related]
19. Schizophrenia as a genetic morphism.
Hoffer A
Nature; 1965 Oct; 208(5007):306. PubMed ID: 5882469
[No Abstract] [Full Text] [Related]
20. Studies on aminochromes. V. Excessive hemolysis associated with the formation of rheomelanins during incubation of adrenochrome and adrenolutin in the bloods of chronic schizophrenic patients.
Hegedus ZL; Altschule MD
Arch Int Pharmacodyn Ther; 1970 Jul; 186(1):48-53. PubMed ID: 5473179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
